Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia

Brain Research

Volumn 1069, Issue 1, 2006, Pages 227-234

  Lumenta, D B ^a   Plesnila, N ^a   Klasner B ^a   Baethmann, A ^a   Pruneau, D ^b   Schmid Elsaesser, R ^a   Zausinger, S ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Laboratoires Fournier SA   (France)

Author keywords

Bradykinin; Bradykinin B2 receptor antagonization; Cerebral ischemia; Focal; Laser Doppler flowmetry; Neuroprotection

Indexed keywords

ANATIBANT; BRADYKININ B2 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; HISTOLOGY; LASER DOPPLER FLOWMETRY; MALE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LASER-DOPPLER FLOWMETRY; MALE; NEUROPROTECTIVE AGENTS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA;

EID: 31344464436     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.11.043     Document Type: Article

References (68)

1. N.J. Abbott Inflammatory mediators and modulation of blood-brain barrier permeability Cell Mol. Neurobiol. 20 2000 131 147
2. A.H.A. Heart Disease and Stroke Statistics-2004 Update 2003 American Heart Association (AHA) 52
3. A. Baethmann, K. Maier-Hauff, O. Kempski, A. Unterberg, M. Wahl, and L. Schurer Mediators of brain edema and secondary brain damage Crit. Care Med. 16 1988 972 978
4. F.C. Barone, and G.Z. Feuerstein Inflammatory mediators and stroke: new opportunities for novel therapeutics J. Cereb. Blood Flow Metab. 19 1999 819 834
5. K.D. Bhoola, C.D. Figueroa, and K. Worthy Bioregulation of kinins: kallikreins, kininogens, and kininases Pharmacol. Rev. 44 1992 1 80
6. A.M. Brambrink, L. Kopacz, A. Astheimer, H. Noga, A. Heimann, and O. Kempski Control of brain temperature during experimental global ischemia in rats J. Neurosci. Methods 92 1999 111 122
7. T. Brott, and J. Bogousslavsky Treatment of acute ischemic stroke N. Engl. J. Med. 343 2000 710 722
8. E.Y. Chen, D.F. Emerich, R.T. Bartus, and J.H. Kordower B2 bradykinin receptor immunoreactivity in rat brain J. Comp. Neurol. 427 2000 1 18
9. A.J. Cholewinski, G. Stevens, A.M. McDermott, and G.P. Wilkin Identification of B2 bradykinin binding sites on cultured cortical astrocytes J. Neurochem. 57 1991 1456 1458
10. R. Couture, M. Harrisson, R.M. Vianna, and F. Cloutier Kinin receptors in pain and inflammation Eur. J. Pharmacol. 429 2001 161 176
11. G.J. del Zoppo, R. von Kummer, and G.F. Hamann Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke J. Neurol. Neurosurg. Psychiatry 65 1998 1 9
12. L. Ding-Zhou, I. Margaill, B. Palmier, D. Pruneau, M. Plotkine, and C. Marchand-Verrecchia LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia Br. J. Pharmacol. 139 2003 1539 1547
13. A.S. Easton, and N.J. Abbott Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier Brain Res. 953 2002 157 169
14. E.F. Ellis, M.L. Heizer, G.S. Hambrecht, S.A. Holt, J.M. Stewart, and R.J. Vavrek Inhibition of bradykinin- and kallikrein-induced cerebral arteriolar dilation by a specific bradykinin antagonist Stroke 18 1987 792 795
15. M. Fisher, and T.G. Brott Emerging therapies for acute ischemic stroke: new therapies on trial Stroke 34 2003 359 361
16. P.C. Francel Bradykinin and neuronal injury J. Neurotrauma 9 Suppl. 1 1992 S27 S45
17. J.H. Garcia, K.F. Liu, Y. Yoshida, J. Lian, S. Chen, and G.J. del Zoppo Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat) Am. J. Pathol. 144 1994 188 199
18. A. Gecse, Z. Mezei, and G. Telegdy The effect of bradykinin and its fragments on the arachidonate cascade of brain microvessels Adv. Exp. Med. Biol. 247A 1989 249 254
19. G. Gimpl, W. Walz, C. Ohlemeyer, and H. Kettenmann Bradykinin receptors in cultured astrocytes from neonatal rat brain are linked to physiological responses Neurosci. Lett. 144 1992 139 142
20. C. Gorlach, and M. Wahl Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide Peptides 17 1996 1373 1378
21. O. Gotoh, T. Asano, T. Koide, and K. Takakura Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin Stroke 16 1985 101 109
22. M. Groger, D. Lebesgue, D. Pruneau, J. Relton, S.W. Kim, J. Nussberger, and N. Plesnila Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice J. Cereb. Blood Flow Metab. 25 2005 978 989
23. C.A. Gunnett, D.D. Lund, M.A. Howard III, Y. Chu, F.M. Faraci, and D.D. Heistad Gene transfer of inducible nitric oxide synthase impairs relaxation in human and rabbit cerebral arteries Stroke 33 2002 2292 2296
24. W. Hacke, G. Donnan, C. Fieschi, M. Kaste, R. von Kummer, J.P. Broderick, T. Brott, M. Frankel, J.C. Grotta, E.C. Haley Jr., T. Kwiatkowski, S.R. Levine, C. Lewandowski, M. Lu, P. Lyden, J.R. Marler, S. Patel, B.C. Tilley, G. Albers, E. Bluhmki, M. Wilhelm, and S. Hamilton Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 2004 768 774
25. S. Hatashita, and J.T. Hoff Brain edema and cerebrovascular permeability during cerebral ischemia in rats Stroke 21 1990 582 588
26. H. Heitsch Non-peptide antagonists and agonists of the bradykinin B(2) receptor Curr. Med. Chem. 9 2002 913 928
27. J.F. Hess, J.A. Borkowski, G.S. Young, C.D. Strader, and R.W. Ransom Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor Biochem. Biophys. Res. Commun. 184 1992 260 268
28. E. Hosli, and L. Hosli Autoradiographic localization of binding sites for neuropeptide Y and bradykinin on astrocytes NeuroReport 4 1993 159 162
29. T. Kamitani, M.H. Little, and E.F. Ellis Evidence for a possible role of the brain kallikrein-kinin system in the modulation of the cerebral circulation Circ. Res. 57 1985 545 552
30. T. Kamiya, Y. Katayama, F. Kashiwagi, and A. Terashi The role of bradykinin in mediating ischemic brain edema in rats Stroke 24 1993 571 575
31. D.W. Krieger, A.M. Demchuk, S.E. Kasner, M. Jauss, and L. Hantson Early clinical and radiological predictors of fatal brain swelling in ischemic stroke Stroke 30 1999 287 292
32. J. Lehmberg, J. Beck, A. Baethmann, and E. Uhl Bradykinin antagonists reduce leukocyte-endothelium interactions after global cerebral ischemia J. Cereb. Blood Flow Metab. 23 2003 441 448
33. T.N. Lin, Y.Y. He, G. Wu, M. Khan, and C.Y. Hsu Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats Stroke 24 1993 117 121
34. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat. Rev., Neurosci. 4 2003 399 415
35. L.G. Makevnina, I.P. Lomova, N. Zubkov Yu, and V.B. Semenyutin Kininogen consumption in cerebral circulation of humans during brain ischemia and postischemic reperfusion Braz. J. Med. Biol. Res. 27 1994 1955 1963
36. F. Marceau, J.F. Hess, and D.R. Bachvarov The B1 receptors for kinins Pharmacol. Rev. 50 1998 357 386
37. S.A. Menzies, J.T. Hoff, and A.L. Betz Extravasation of albumin in ischaemic brain oedema Acta Neurochir., Suppl. (Wien) 51 1990 220 222
38. C.A. Molina, J. Montaner, S. Abilleira, B. Ibarra, F. Romero, J.F. Arenillas, and J. Alvarez-Sabin Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke Stroke 32 2001 1079 1084
39. T. Neumann-Haefelin, A. Kastrup, A. de Crespigny, M.A. Yenari, T. Ringer, G.H. Sun, and M.E. Moseley Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation Stroke 31 2000 1965 1972 discussion 1972-3
40. M. Noda, Y. Kariura, T. Amano, Y. Manago, K. Nishikawa, S. Aoki, and K. Wada Expression and function of bradykinin receptors in microglia Life Sci. 72 2003 1573 1581
41. N. Plesnila, J. Schulz, M. Stoffel, J. Eriskat, D. Pruneau, and A. Baethmann Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats J. Neurotrauma 18 2001 1049 1058
42. D.M. Raidoo, and K.D. Bhoola Kinin receptors on human neurones J. Neuroimmunol. 77 1997 39 44
43. D.M. Raidoo, R. Ramsaroop, S. Naidoo, W. Muller-Esterl, and K.D. Bhoola Kinin receptors in human vascular tissue: their role in atheromatous disease Immunopharmacology 36 1997 153 160
44. D. Regoli, L.H. Pheng, S.N. Allogho, X.K. Nguyen-Le, and F. Gobeil Receptors for kinins: from classical pharmacology to molecular biology Immunopharmacology 33 1996 116 122
45. D. Regoli, A. Rizzi, G. Calo, S. Nsa Allogho, and F. Gobeil B1 and B2 kinin receptors in various species Immunopharmacology 36 1997 143 147
46. J. Relton, N.J. Rothwell, and E.T. Whalley Blockade of the bradykinin B1-receptor reverses the neuroprotective effect of b2-receptor antagonism after focal cerebral ischemia in the rat Br. J. Pharmacol. 120 1997 76
47. J.K. Relton, V.E. Beckey, W.L. Hanson, and E.T. Whalley CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion Stroke 28 1997 1430 1436
48. W.D. Rosamond, A.R. Folsom, L.E. Chambless, C.H. Wang, P.G. McGovern, G. Howard, L.S. Copper, and E. Shahar Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort Stroke 30 1999 736 743
49. W.I. Rosenblum Hydroxyl radical mediates the endothelium-dependent relaxation produced by bradykinin in mouse cerebral arterioles Circ. Res. 61 1987 601 603
50. L. Schilling, and M. Wahl Mediators of cerebral edema Adv. Exp. Med. Biol. 474 1999 123 141
51. J. Schulz, N. Plesnila, J. Eriskat, M. Stoffel, D. Pruneau, and A. Baethmann LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats Acta Neurochir., Suppl. 76 2000 137 139
52. S. Schwab, T. Steiner, A. Aschoff, S. Schwarz, H.H. Steiner, O. Jansen, and W. Hacke Early hemicraniectomy in patients with complete middle cerebral artery infarction Stroke 29 1998 1888 1893
53. M. Schwaninger, S. Sallmann, N. Petersen, A. Schneider, S. Prinz, T.A. Libermann, and M. Spranger Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB J. Neurochem. 73 1999 1461 1466
54. C.G. Sobey Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy? Br. J. Pharmacol. 139 2003 1369 1371
55. C.G. Sobey, D.D. Heistad, and F.M. Faraci Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels Stroke 28 1997 2290 2294
56. J.F. Stover, N.K. Dohse, and A.W. Unterberg Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats J. Neurosurg. 92 2000 853 859
57. M. Takano, M. Horie, M. Narahara, M. Miyake, and H. Okamoto Expression of kininogen mRNAs and plasma kallikrein mRNA by cultured neurons, astrocytes and meningeal cells in the rat brain Immunopharmacology 45 1999 121 126
58. A. Unterberg, M. Wahl, and A. Baethmann Effects of bradykinin on permeability and diameter of pial vessels in vivo J. Cereb. Blood Flow Metab. 4 1984 574 585
59. C. Verrecchia, C. Mesenge, and M. Plotkine Neuroprotective effect of LF16-0687 Ms, a bradykinin B2 receptor antagonist, on a model of traumatic brain injury in mice Restor. Neurol. Neurosci. 16 2000 177 178
60. S. Wagner, P. Kalb, M. Lukosava, U. Hilgenfeldt, and M. Schwaninger Activation of the tissue kallikrein-kinin system in stroke J. Neurol. Sci. 202 2002 75 76
61. M. Wahl, A.R. Young, L. Edvinsson, and F. Wagner Effects of bradykinin on pial arteries and arterioles in vitro and in situ J. Cereb. Blood Flow Metab. 3 1983 231 237
62. M. Wahl, E.T. Whalley, A. Unterberg, L. Schilling, A.A. Parsons, A. Baethmann, and A.R. Young Vasomotor and permeability effects of bradykinin in the cerebral microcirculation Immunopharmacology 33 1996 257 263
63. E.T. Whalley, and M. Wahl Analysis of bradykinin receptor mediating relaxation of cat cerebral arteries in vivo and in vitro Naunyn-Schmiedeberg's Arch. Pharmacol. 323 1983 66 71
64. D. Woo, J. Gebel, R. Miller, R. Kothari, T. Brott, J. Khoury, S. Salisbury, R. Shukla, A. Pancioli, E. Jauch, and J. Broderick Incidence rates of first-ever ischemic stroke subtypes among blacks: a population-based study Stroke 30 1999 2517 2522
65. S. Zausinger, E. Hungerhuber, A. Baethmann, H. Reulen, and R. Schmid-Elsaesser Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms Brain Res. 863 2000 94 105
66. S. Zausinger, A. Baethmann, and R. Schmid-Elsaesser Anesthetic methods in rats determine outcome after experimental focal cerebral ischemia: mechanical ventilation is required to obtain controlled experimental conditions Brain Res. Protoc. 9 2002 112 121
67. S. Zausinger, D.B. Lumenta, D. Pruneau, R. Schmid-Elsaesser, N. Plesnila, and A. Baethmann Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia Brain Res. 950 2002 268 278
68. Q. Zhao, H. Memezawa, M.L. Smith, and B.K. Siesjo Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament Brain Res. 649 1994 253 259